HighVista Strategies’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History
Bought
Maintained
Sold
HighVista Strategies's ONCE Position: Q4 2019 in Review
HighVista Strategies sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 23,271 shares — an estimated $2.26M sold.
HighVista Strategies first reported a position in ONCE in Q2 2019 and held it in 2 quarters. The position peaked at $2.38M in Q2 2019. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.
- HighVista Strategies reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
- HighVista Strategies sold 23,271 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $2.26M.
- HighVista Strategies first reported a position in Spark Therapeutics, Inc. Common Stock in Q2 2019 and held it in 2 quarters.
- HighVista Strategies's Spark Therapeutics, Inc. Common Stock position peaked at $2.38M in Q2 2019.
- 0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.
Based on HighVista Strategies's 13F filing for Q4 2019, filed 14 Feb 2020.